Last updated on December 2017

Healthy AL 0438-0004 Part A

Brief description of study

ICON Early Phase Services is conducting a research study for healthy adults ages 18-49. This is a first in human study to test the immunogenicity of an investigational drug being developed as an anthrax vaccine. The study drugs will be administered as a nasal spray or as a subcutaneous injection.

Clinical Study Identifier: TX155261

Contact Investigators or Research Sites near you

Start Over


ICON Early Phase Services/CRU
San Antonio, TX USA
  Connect »